Wayne Everett Childers

USPTO Granted Patents = 38 (Patent Applications = 11)

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 16)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 67(Granted Patents)

Location History:

Levittown, PA (US) (2000 - 2003)
New Hope, PA (US) (2001 - 2024)

Company Filing History:

American Home Products Corporation

patents

4. 5 out of 971

University of Rochester

patents

5. 4 out of 730

University of Nebraska

patents

6. 1 out of 6

Shifa Biomedical Corporation

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12465582 - (S)-2-amino-6-((3-aminopropyl)amino)hexanoic acid (APL) for use in the treatment of non-alcoholic steatohepatitis (NASH), liver inflammation, hepatocellular ballooning, liver fibrosis and steatosis (2025-11-11),

2. 11873267 - Functionalized N,N-dialkylamino phenyl ethers and their method of use (2024-01-16),

3. 11787794 - Aminothiazole compounds and methods using same (2023-10-17),

4. 11596615 - Compositions and methods for treatment of insulin resistance (2023-03-07),

5. 11325883 - Functionalized N,N-dialkylamino phenyl ethers and their method of use (2022-05-10),

6. 10759750 - Beta lactams as modulators of glutamate uptake and methods for use thereof (2020-09-01),

7. 10729670 - Compositions and methods for treatment of insulin resistance (2020-08-04),

8. 10513516 - Aminothiazole compounds and methods using same (2019-12-24),

9. 10131637 - Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases (2018-11-20),

10. 10028931 - Synergistic compositions for treating microbial infections (2018-07-24),

11. 9975879 - Beta lactams as modulators of glutamate uptake and methods for use thereof (2018-05-22),

12. 9725436 - Cytochrome P450 inhibitors and their method of use (2017-08-08),

13. 9693999 - Small molecule RNase inhibitors and methods of use (2017-07-04),

14. 9585380 - SSAT mRNA translation repression and activation (2017-03-07),

15. 9517230 - Small molecule RNase inhibitors and methods of use (2016-12-13),

Title: Wayne Everett Childers: Pioneering Innovations in Pharmaceutical Compositions

Introduction:

Wayne Everett Childers, a prolific inventor based in New Hope, PA (US), has made significant contributions to the field of pharmaceutical compositions. With an impressive portfolio of 37 patents, Childers is known for his groundbreaking work in developing novel compounds for the treatment of various diseases.

Latest Patents:

Childers' latest patents showcase his innovative approach to addressing complex medical conditions. One notable invention is the Functionalized N,N-dialkylamino phenyl ethers, which have shown promise in treating diseases associated with lysosomal storage dysfunction like Gaucher's disease. Additionally, his work on aminothiazole compounds demonstrates their potential in preventing and treating cancer, offering new hope for patients in need.

Career Highlights:

Throughout his career, Childers has been associated with esteemed organizations such as Wyeth and Temple University. At Wyeth, now known as Pfizer, Childers likely played a vital role in driving research and development efforts in pharmaceuticals. Temple University, part of the Commonwealth System of Higher Education, provided him with a platform to further his innovative pursuits in the realm of drug discovery.

Collaborations:

Childers has collaborated closely with notable individuals in the field, including Michael G. Kelly and Magid A. Abou-Gharbia. Together, they have worked towards advancing the frontiers of pharmaceutical science, combining their expertise to create impactful solutions for pressing medical challenges.

Conclusion:

Wayne Everett Childers' dedication to innovation and his remarkable contributions to the field of pharmaceutical compositions have left a lasting impact on healthcare. His pioneering inventions continue to drive progress in the quest for improved treatments and therapies, offering hope to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.